• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadence Welcomes Bob White to Board of Directors

    9/12/24 10:57:00 AM ET
    $SNN
    Industrial Specialties
    Health Care
    Get the next $SNN alert in real time by email

    STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence, Inc., a leading provider of vertically integrated contract manufacturing solutions to the MedTech and Pharma markets, is pleased to announce the appointment of Bob White to its Board of Directors.  Mr. White brings over 25 years of business leadership experience and a proven track record in operational excellence, technological innovation, and strategic growth to Cadence.

    Cadence Welcomes Bob White to its Board of Directors, September 2024.

    Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM.  He recently served as Executive Vice President and Group President for Medtronic, where he led five global businesses with 25,000 employees across 70 countries and 13 manufacturing facilities, achieving consistent above-market growth.  During his tenure, he also successfully completed seven acquisitions, a joint venture, and a multi-billion-dollar divestiture. 

    "Bob will be an excellent addition to our Board," stated Matt Jennings, Cadence's Chairman of the Board.  "His impressive track record in global business leadership and his commitment to innovation and growth will be instrumental as Cadence continues to advance its strategic goals and drive success, and he will be valuable to both the Board and Cadence's leadership team with their go-to market approach."

    In addition, Mr. White currently serves as an Independent Director for Smith & Nephew (NYSE:SNN) and formerly held board positions at Mozarc Medical and CARE Hospitals, a multi-specialty healthcare provider with 14 hospitals in six cities across five states of India.

    He holds an MBA from Case Western Reserve University and a Bachelor of Business Administration from Cleveland State University.  His extensive medical device manufacturing experience and strategic vision make him a valuable addition to Cadence's Board of Directors.

    About Cadence, Inc. – Cadence is a vertically integrated, medical device contract manufacturing organization serving the medical device, diagnostics, and drug delivery markets, providing best-in-class product design and development support through complete manufacturing of finished devices.  Cadence employs approximately 800 people worldwide with its corporate headquarters in Staunton, Virginia and additional locations in Connecticut, Pennsylvania, Rhode Island, Wisconsin, Florida, and Costa Rica.  For more information on Cadence, please visit our website at cadenceinc.com. 

    Cadence, Inc. Logo, September 2024.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cadence-welcomes-bob-white-to-board-of-directors-302246732.html

    SOURCE Cadence, Inc.

    Get the next $SNN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNN

    DatePrice TargetRatingAnalyst
    6/4/2026Buy → Hold
    Kepler
    12/15/2025Outperform → Sector Perform
    RBC Capital Mkts
    10/14/2025$37.50Outperform → Mkt Perform
    Bernstein
    4/25/2025Buy → Hold
    HSBC Securities
    3/12/2025Buy → Neutral
    UBS
    11/6/2024Buy → Hold
    Berenberg
    11/1/2024Buy → Hold
    Deutsche Bank
    7/24/2024Buy
    Deutsche Bank
    More analyst ratings

    $SNN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Smith & Nephew downgraded by Kepler

    Kepler downgraded Smith & Nephew from Buy to Hold

    6/4/26 8:44:15 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith & Nephew downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded Smith & Nephew from Outperform to Sector Perform

    12/15/25 9:57:35 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Smith & Nephew downgraded by Bernstein with a new price target

    Bernstein downgraded Smith & Nephew from Outperform to Mkt Perform and set a new price target of $37.50

    10/14/25 8:42:59 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    SEC Filings

    View All

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    6/17/26 6:38:33 AM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    6/11/26 6:14:33 AM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Smith & Nephew SNATS Inc.

    6-K - SMITH & NEPHEW PLC (0000845982) (Filer)

    6/4/26 11:24:22 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Leadership Updates

    Live Leadership Updates

    View All

    Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee.  As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value.  Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy

    6/23/25 8:00:00 AM ET
    $LAZ
    $SNN
    Investment Managers
    Finance
    Industrial Specialties
    Health Care

    Cadence Welcomes Bob White to Board of Directors

    STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence, Inc., a leading provider of vertically integrated contract manufacturing solutions to the MedTech and Pharma markets, is pleased to announce the appointment of Bob White to its Board of Directors.  Mr. White brings over 25 years of business leadership experience and a proven track record in operational excellence, technological innovation, and strategic growth to Cadence. Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM.  He recent

    9/12/24 10:57:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower

    Issued on behalf of Conexeu Sciences Inc.A clutch of new directors with Fortune 500 finance, M&A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.RENO, Nev., June 16, 2026 /CNW/ -- American News Group News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a promising platform into a real business. The names a young company recruits in that window say a great deal about its ambitions. On June 1

    6/16/26 8:15:00 AM ET
    $ABBV
    $ESTA
    $SNN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties
    Medical/Dental Instruments

    A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

    NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — In healthcare, the market tends to perk up when a company stops speaking in broad platform language and starts showing real progress toward the FDA. That is what makes the latest update from Conexeu Sciences Inc. (NASDAQ:CNXU) — issued from Reno, Nevada on June 8, 2026 — worth a closer look. A newly Nasdaq-listed regenerative-tissue company carrying a market capitalization in the hundreds of millions, Conexeu has moved its lead CXU™ wound-care program further into manufacturing scale-up and regulatory preparation as it works toward a planned first-quarter 2027 510(k) submission. Companies mentioned: Conexeu Scien

    6/9/26 9:54:59 AM ET
    $IART
    $MDXG
    $SNN
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Specialties

    Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

    Smith+Nephew ((LSE: SN, NYSE:SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next‑generation CORI◊ XT Handheld Robotics Platform, marking an important milestone in the clinical introduction of its latest handheld robotics technology. CORI XT Handheld Robotic Platform is designed to be the single handheld robotics platform for all orthopaedic needs - partial to revision knee, hip*, and anatomic and reverse shoulders - with a footprint tailored to the unique needs of hospitals and ambulatory surgical suites settings. These early cases represent the first use of CORI XT Platform across both knee and shoulder arthroplasty a

    6/8/26 1:22:55 PM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: Plc Nephew & Smith claimed ownership of 5,428,680 units of Class A Common Stock and claimed ownership of 16,534,814 units of Class B Common Stock

    3 - SMITH & NEPHEW PLC (0000845982) (Reporting)

    2/12/21 6:00:30 AM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Financials

    Live finance-specific insights

    View All

    Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

    Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder repair business with the most comprehensive suite of technologies available for rotator cuff repair (RCR). Integrity Orthopaedics is a US‑based, early‑stage commercial developer of Tendon Seam™, an innovative and disruptive biomechanical RCR system designed to significantly reduce re‑tear rates and improve patient outcomes versus the current standard of care. Tendon Seam™ allows for a novel repair stitch configuration with multiple points of fixation. Its patented microanchors, continuous sutu

    1/21/26 12:15:00 PM ET
    $SNN
    Industrial Specialties
    Health Care

    Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

    New York, United States, March 03, 2025 (GLOBE NEWSWIRE) -- The global demand for wound care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Download Free Sample Report PDF @ https://straitsresearc

    3/3/25 8:20:00 AM ET
    $SNN
    Industrial Specialties
    Health Care

    Wound Care Market Will Reach USD 31.81 Billion by 2030 on the Back of Growth in the North American Market

    New York, United States, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The global demand for Wound Care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Get a Free Sample Copy of This Report https://stra

    8/29/22 3:20:00 PM ET
    $SNN
    Industrial Specialties
    Health Care

    $SNN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Smith & Nephew SNATS Inc.

    SC 13D - SMITH & NEPHEW PLC (0000845982) (Subject)

    7/9/24 12:00:10 PM ET
    $SNN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - SMITH & NEPHEW PLC (0000845982) (Subject)

    2/3/21 1:13:21 PM ET
    $SNN
    Industrial Specialties
    Health Care